The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Open accessPublished version of a preprint
Abstract
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. A familial aggregation of pancreatic cancer has been established, but the cause of this aggregation in most families is unknown. To determine the genetic basis of susceptibility in these families, we sequenced the germline genomes of 638 patients with familial pancreatic cancer and the tumor exomes of 39 familial pancreatic adenocarcinomas. Our analyses support the role of previously identified familial pancreatic cancer susceptibility genes such as BRCA2, CDKN2A, and ATM, and identify novel candidate genes harboring rare, deleterious germline variants for further characterization. We also show how somatic point mutations that occur during hematopoiesis can affect the interpretation of genome-wide studies of hereditary traits. Our observations have important implications for the etiology of pancreatic cancer and for the identification of susceptibility genes in other common cancer types. Significance: The genetic basis of disease susceptibility in the majority of patients with familial pancreatic cancer is unknown. We whole genome sequenced 638 patients with familial pancreatic cancer and demonstrate that the genetic underpinning of inherited pancreatic cancer is highly heterogeneous. This has significant implications for the management of patients with familial pancreatic cancer. Cancer Discov; 6(2); 166–75. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 109
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deleterious variants in the known pancreatic cancer susceptibility genes account for ~10–20% of the familial clustering of pancreatic cancer.”
In the citing paper
“Pancreatic surveillance is recommended for carriers of germline deleterious variants in cancer susceptibility gene,22–26: BRCA2, ATM, BRCA1, PALB2, CDKN2A, STK11, MLH1 and MSH2.”
In the citing paper
“Our data show, for the first time, that predisposition to MPM is very heterogeneous, similar to that reported for pancreatic cancer and other cancer types [17,18,38].”
From Germline Mutations in DNA Repair Genes Predispose Asbestos-Exposed Patients to Malignant Pleural Mesothelioma (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Self-citationMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Cited by
Sorted by citations
Items 101–200 of 359
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
Williamson, T., de Abreu, M. C., Trembath, D. G., Brayton, C. F., Kang, B., Mendes, T. B., de Assumpção, P. P., Cerutti, J. M., & Riggins, G. J. (2021) · Oncotarget · doi:10.18632/oncotarget.28014 · Cited by 36
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes
Slavin, T. P., Neuhausen, S. L., Nehoray, B., Niell‐Swiller, M., Solomon, I. B., Rybak, C., Blazer, K. R., Adamson, A. W., Yang, K., Sand, S. R., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0019-5 · Cited by 33
Self-citationEpigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Čierniková, S., Earl, J., García‐Bermejo, L., Števurková, V., Carrato, A., & Smolková, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114091 · Cited by 36
Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic
Borecká, M., Zemánková, P., Vočka, M., Souček, P., Soukupová, J., Kleiblová, P., Sevcik, J., Kleibl, Z., & Janatová, M. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.03.003 · Cited by 33
Abrams, S. L., Lertpiriyapong, K., Yang, L. V., Martelli, A. M., Cocco, L., Ratti, S., Falasca, M., Murata, R. M., Rosalen, P. L., Lombardi, P., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.06.002 · Cited by 36
Susceptibility of ATM-deficient pancreatic cancer cells to radiation
Ayars, M., Eshleman, J. R., & Goggins, M. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1312236 · Cited by 32
Self-citationWhole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1
Noë, M., Pea, A., Luchini, C., Felsenstein, M., Barbi, S., Bhaijee, F., Yonescu, R., Ning, Y., Adsay, V. N., Zamboni, G., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0082-y · Cited by 32
Self-citationRoger, É., Gout, J., Arnold, F., Beutel, A. K., Müller, M., Abaei, A., Barth, T. F. E., Rasche, V., Seufferlein, T. T. W., Perkhofer, L., et al. (2020) · Cells · doi:10.3390/cells9092110 · Cited by 31
Astiazarán-Symonds, E., & Goldstein, A. M. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01806-y · Cited by 34
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
Mota, A., Oltra, S. S., Selenica, P., Moiola, C. P., Casas‐Arozamena, C., López-Gil, C., Díaz, E., Gatius, S., Ruiz-Miró, M., Calvo, A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02221-0 · Cited by 30
ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
Nanda, N., & Roberts, N. J. (2020) · Genes · doi:10.3390/genes11010108 · Cited by 30
Self-citationMartínez‐Useros, J., Martin-Galan, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13020322 · Cited by 29
Smith, A. L., Wong, C., Cuggia, A., Borgida, A., Holter, S., Hall, A., Connor, A. A., Bascuñana, C., Asselah, J., Bouganim, N., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00098 · Cited by 29
Self-citationPharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges
Diab, M., Azmi, A. S., Mohammad, R. M., & Philip, P. A. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1561869 · Cited by 28
Bagni, K., Chen, I. M., Johansen, A. Z., Dehlendorff, C., Jensen, B. V., Hansen, C. P., Hasselby, J. P., Holländer, N. H., Nissen, M., Bjerregaard, J. K., et al. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13219 · Cited by 30
Merkle, J., Breunig, M., Schmid, M., Allgöwer, C., Krüger, J., Melzer, M. K., Bens, S., Siebert, R., Perkhofer, L., Azoitei, N., et al. (2021) · Cancers · doi:10.3390/cancers13205139 · Cited by 27
Seufferlein, T. T. W., Mayerle, J. V., Böck, S., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1856-7346 · Cited by 29
Overbeek, K. A., Koopmann, B. D. M., Levink, I. J. M., Tacelli, M., Erler, N. S., Arcidiacono, P. G., Ausems, M. G. E. M., Wagner, A., van Eijck, C. H. J., Koerkamp, B. G., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.03.035 · Cited by 28
Yang, X. R., Rotunno, M., Xiao, Y., Ingvar, C., Helgadóttir, H., Pastorino, L., van Doorn, R., Bennett, H. R., Graham, C., Sampson, J. N., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1715-1 · Cited by 27
Hutchings, D., Jiang, Z., Skaro, M. F., Weiss, M. J., Wolfgang, C. L., Makary, M. A., He, J. P., Cameron, J. L., Zheng, L., Klimstra, D. S., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0317-6 · Cited by 26
Self-citationTargeting DNA Damage Repair Mechanisms in Pancreas Cancer
Perkhofer, L., Golan, T., Cuyle, P.-J. A., Matysiak‐Budnik, T., Laethem, J. V., Macarulla, T. M., Cauchin, E., Kleger, A., Beutel, A. K., Gout, J., et al. (2021) · Cancers · doi:10.3390/cancers13174259 · Cited by 25
Kawamoto, M., Kohi, S., Abe, T., Dbouk, M. H., Macgregor‐Das, A. M., Koi, C., Song, K. B., Borges, M. W., Sugimine, R., Laheru, D. A., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33883 · Cited by 26
Self-citationDalmasso, B., Puccini, A., Catalano, F., Borea, R., Iaia, M. L., Bruno, W., Fornarini, G., Sciallero, S., Rebuzzi, S. E., & Ghiorzo, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094709 · Cited by 25
Rotunno, M., Barajas, R., Clyne, M., Hoover, E., Simonds, N. I., Lam, T. K., Mechanic, L. E., Goldstein, A. M., & Gillanders, E. M. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1551 · Cited by 25
Lost in translation: returning germline genetic results in genome-scale cancer research
Initiative, A. P. C. G., Johns, A. L., McKay, S. H., Humphris, J. L., Pinese, M., Chantrill, L. A., Mead, R. S., Tucker, K., Andrews, L., Goodwin, A., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0430-4 · Cited by 79
Pancreatic cancer in young adults: changes, challenges, and solutions
Primavesi, F., Stättner, S., Schlick, K., Kiesslich, T., Mayr, C., Klieser, E., Urbas, R., & Neureiter, D. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s176700 · Cited by 24
Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer
Liu, Z., Zhang, X., Zhao, Q., Chen, Y., Sheng, H., He, C., Sun, Y., Lai, M.-Y., Wu, M., Zuo, Z., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.45836 · Cited by 24
Self-citationTakai, E., Nakamura, H. K., Chiku, S., Kubo, E., Ohmoto, A., Totoki, Y., Shibata, T., Higuchi, R., Yamamoto, M., Furuse, J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004213 · Cited by 24
Kimura, H., Paranal, R. M., Nanda, N., Wood, L. D., Eshleman, J. R., Hruban, R. H., Goggins, M. G., Klein, A. P., The Familial Pancreatic Cancer Genome Sequencing Project, & Roberts, N. J. (2022) · eLife · doi:10.7554/elife.71137 · Cited by 23
Self-citationScreening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer, B. L., Lee, J. W., Roberts, N. J., Chu, L. C. H., Lennon, A. M., Klein, A. P., Eshleman, J. R., Fishman, E. K., Canto, M. I., Goggins, M., et al. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2217354 · Cited by 24
Self-citationGermline Aberrations in Pancreatic Cancer: Implications for Clinical Care
Casolino, R., Corbo, V., Beer, P. A., Hwang, C., Paiella, S., Silvestri, V., Ottini, L., & Biankin, A. V. (2022) · Cancers · doi:10.3390/cancers14133239 · Cited by 24
Stosic, K., Senar, O. A., Tarfouss, J., Bouchart, C., Navez, J., Laethem, J. V., & Arsenijevic, T. (2023) · Cells · doi:10.3390/cells13010003 · Cited by 22
Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers
de Mestier, L., Danset, J. B., Neuzillet, C., Rebours, V., Cros, J. F., Soufir, N., & Hammel, P. R. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0269 · Cited by 23
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Lesueur, F., Easton, D. F., Renault, A., Tavtigian, S. V., Bernstein, J. L., Kote‐Jarai, Z., Eeles, R. A., Plaseska-Karanfia, D., Feliubadaló, L., Spanish ATM working group, et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00248-y · Cited by 21
Self-citationZhao, Y., Yao, H., Yang, K., Han, S., Chen, S., Li, Y., Chen, S., Huang, K., Lian, G., & Li, J. (2022) · Biomaterials Science · doi:10.1039/d2bm01039a · Cited by 21
Current Screening Strategies for Pancreatic Cancer
Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21
Tian, C., Li, X., & Ge, C. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00322-2 · Cited by 21
Ramesh, R. P. G., Yasmin, H., Ponnachan, P., al-Ramadi, B. K., Kishore, U., & Joseph, A. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573522 · Cited by 22
The German National Case Collection for Familial Pancreatic Cancer (FaPaCa)
Bartsch, D. K., Matthäi, E., Mintziras, I., Bauer, C. A., Figiel, J. H., Sina-Boemers, M., Gress, T. M., Langer, P., & Slater, E. P. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0004 · Cited by 21
Oyón, D., López-Pascual, A., Castelló-Uribe, B., Uriarte, I., Orsi, G., Llorente, S., Elurbide, J., Adán-Villaescusa, E., Valbuena-Goiricelaya, E., Irigaray-Miramon, A., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03268-5 · Cited by 22
Lim, C. H., Cho, Y. S., Choi, J. Y., Lee, K.-H., Min, J. H., & Hyun, S. H. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04850-7 · Cited by 19
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
Zhang, X., Xu, Z. Q., Dai, X., Zhang, X., & Wang, X. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104860 · Cited by 18
Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer
Liu, J., Mroczek, M., Mach, A., Stępień, M., Aplas, A., Pronobis‐Szczylik, B., Bukowski, S., Mielczarek, M., Gajewska, E., Topolski, P., et al. (2023) · Cancers · doi:10.3390/cancers15030779 · Cited by 18
Toss, A., Venturelli, M., Molinaro, E., Pipitone, S., Barbieri, E., Marchi, I., Tenedini, E., Artuso, L., Castellano, S., Marino, M., et al. (2019) · Cancers · doi:10.3390/cancers11020193 · Cited by 17
Pancreatic cancer pathology viewed in the light of evolution
Noë, M., Hong, S., Wood, L. D., Thompson, E. D., Roberts, N. J., Goggins, M., Klein, A. P., Eshleman, J. R., Kern, S. E., & Hruban, R. H. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09953-z · Cited by 17
Self-citationInherited Pancreatic Cancer Syndromes and High-Risk Screening
Biller, L. H., Wolpin, B. M., & Goggins, M. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.002 · Cited by 19
Self-citationRole of Epigenetics in Pancreatic Ductal Adenocarcinoma
Pandey, S., Gupta, V. K., & Lavania, S. (2023) · Epigenomics · doi:10.2217/epi-2022-0177 · Cited by 18
Wong, C., Chen, F., Alirezaie, N., Wang, Y., Cuggia, A., Borgida, A., Holter, S., Lenko, T., Domecq, C., Initiative, A. D. N., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008344 · Cited by 19
Self-citationIntegrated analysis of tumor differentiation genes in pancreatic adenocarcinoma
Xi, T., & Zhang, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193427 · Cited by 17
T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer
Cui, C., Tian, X., Wu, J., Zhang, C., Tan, Q., Guan, X., Dong, B., Zhao, M., Lu, Z., & Hao, C. (2018) · Cancer Science · doi:10.1111/cas.13877 · Cited by 17
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
Dominguez, A. A., Perz, M., Xu, Y., Cedillo, L. G., Huang, O. L., McIntyre, C. A., Vudatha, V., Trevino, J. G., Liu, J., & Wang, P. (2024) · Cancers · doi:10.3390/cancers16213564 · Cited by 17
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives
Molinaro, E., Andrikou, K., Gardini, A. C., & Rovesti, G. (2020) · Cancers · doi:10.3390/cancers12113346 · Cited by 15
An, J., Oh, J., Oh, B., Oh, Y., Ju, J., Kim, W., Kang, H. J., Sung, C. O., & Shim, J. H. (2022) · Hepatology · doi:10.1002/hep.32812 · Cited by 15
The role of molecular testing in pancreatic cancer
Zhen, D. B., Safyan, R. A., Konick, E. Q., Nguyen, R., Pritchard, C. C., & Chiorean, E. G. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231171456 · Cited by 16
PARP Inhibitors in Pancreatic Cancer: From Phase I to Plenary Session
Patel, R., Fein, D. E. C., Bernabe, C., Do, K. J., & Saif, M. W. (2019) · Pancreas - Open Journal · doi:10.17140/poj-3-e011 · Cited by 15
Pancreatic ductal adenocarcinoma in the era of precision medicine
Zheng-Lin, B., & O'Reilly, E. M. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.01.005 · Cited by 16
Cleary, J. M., Wolpin, B. M., Dougan, S. K., Raghavan, S., Singh, H., Huffman, B. M., Sethi, N. S., Nowak, J. A., Shapiro, G. I., Aguirre, A. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1367 · Cited by 16
Models of pancreatic ductal adenocarcinoma
Dennaoui, R., Shrestha, H., & Wagner, K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09989-9 · Cited by 19
Agostini, A., Orlacchio, A., Carbone, C., & Guerriero, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876291 · Cited by 14
The c.657del5 variant in the NBN gene predisposes to pancreatic cancer
Borecká, M., Zemánková, P., Lhota, F., Soukupová, J., Kleiblová, P., Vočka, M., Souček, P., Tichá, I., Kleibl, Z., & Janatová, M. (2016) · Gene · doi:10.1016/j.gene.2016.04.056 · Cited by 15
Germline mutation contribution to chromosomal instability
Chan, S. H., & Ngeow, J. Y. Y. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0062 · Cited by 16
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
Ding, L.-Y., Hou, Y., Kuo, I., Hsu, T.-Y., Tsai, T.-C., Chang, H.-W., Hsu, W.-Y., Tsao, C.-C., Tian, C.-C., Wang, P., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00878-6 · Cited by 14
Self-citationGraham, S., Dmitrieva, M., Costa, D. B. V., Francescone, R., Trujillo, M. A. M., Cukierman, E., & Wood, L. D. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae064 · Cited by 15
Self-citationProteomics in pancreatic cancer
Cai, F., Gu, Y., Ling, Y., Yi, G., Zang, S., Su, T., Liu, Y., Li, A., Wang, D., Zhao, W., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00805-y · Cited by 19
A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis
Pan, H., Diao, H., Zhong, W., Wang, T., Wen, P., & Wu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656564 · Cited by 14
Mastracci, T. L., Apte, M. V., Amundadottir, L. T., Alvarsson, A., Artandi, S. E., Bellin, M. D., Bernal‐Mizrachi, E., Caicedo, A., Campbell‐Thompson, M., Cruz‐Monserrate, Z., et al. (2023) · Diabetes · doi:10.2337/db22-0942 · Cited by 15
Self-citationGuo, K., Zhao, Y., Cao, Y., Li, Y., Yang, M., Tian, Y., Dai, J., Song, L., Ren, S., & Wang, Z. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1115660 · Cited by 14
Bile Acids in Pancreatic Carcinogenesis
Sharma, B., Twelker, K., Nguyen, C., Ellis, S., Bhatia, N. D., Kuschner, Z. D., Agriantonis, A., Agriantonis, G., Arnold, M., Dave, J., et al. (2024) · Metabolites · doi:10.3390/metabo14070348 · Cited by 15
Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
Teo, M. Y., & O'Reilly, E. M. (2016) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.05.04 · Cited by 14
Xiao, R., Wang, F., Wang, T., Zhang, J., Wu, Z., Deng, C., Liao, Y., Zhou, T., Yang, D.-W., Dong, S.-Q., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104267 · Cited by 14
Jinawath, N., Shiao, M., Norris, A. L., Murphy, K. M., Klein, A. P., Yonescu, R., Iacobuzio–Donahue, C. A., Meeker, A. K., Jinawath, A., Yeo, C. J., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22447 · Cited by 14
Self-citationHo, J., Li, X., Zhang, L., Liang, Y., Hu, W., Yau, J. C. W., Chan, H., Gin, T., Chan, M. T. V., Tse, G., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.04.004 · Cited by 14
Roth, S., Apte, M. V., Balachandran, V. P., Biffi, G., Conroy, T., Cukierman, E., Dotan, E., Esposito, I., Grünwald, B. T., Klauß, M., et al. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00699-6 · Cited by 19
Self-citationPantaleo, A., Forte, G., Fasano, C., Signorile, M. L., Sanese, P., Marco, K. D., Nicola, E. D., Latrofa, M., Grossi, V., Disciglio, V., et al. (2023) · Cancers · doi:10.3390/cancers16010056 · Cited by 15
Ding, D., Javed, A. A., Cunningham, D., Teinor, J. A., Wright, M. J., Javed, Z. N., Wilt, C., Parish, L., Hodgin, M. B., Ryan, A., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.039 · Cited by 14
Self-citationCombinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer
Slater, E. P., Wilke, L. M., Böhm, L. B., Strauch, K., Lutz, M., Krasser‐Gercke, N., Matthäi, E., Hemminki, K., Försti, A., Schlesner, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070631 · Cited by 14
Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses
Shevach, J. W., Xu, J., Snyder, N. A., Wei, J., Shi, Z., Tran, H., Zheng, S. L., Beebe‐Dimmer, J., & Cooney, K. A. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.2879 · Cited by 15
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Jacobs, M. F., & Stoffel, E. M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00372-5 · Cited by 15
Self-citationDuktales Adenokarzinom des Pankreas
Gallmeier, E., & Gress, T. M. (2018) · Der Internist · doi:10.1007/s00108-018-0460-z · Cited by 12
Vasen, H. F. A., Boekestijn, B., Ibrahim, I. S., Inderson, A., Bonsing, B. A., de Vos tot Nederveen Cappel, W. H., Feshtali, S., & Wasser, M. N. (2019) · HPB · doi:10.1016/j.hpb.2019.02.013 · Cited by 12
Wang, L., Zhang, S., Yu, X., & Guo, C. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00087 · Cited by 12
Hu, H., Zhu, Y., Pu, N., Burkhart, R. A., Burns, W. R., Laheru, D. A., Zheng, L., He, J. P., Goggins, M., & Yu, J. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.06.019 · Cited by 12
Self-citationSilva, M. P., Ferreira, L. T., Brás, N. F., Torres, L., Brandão, A., Pinheiro, M., Cardoso, M., Resende, A., Vieira, J., Palmeira, C., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01056-z · Cited by 11
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Tamura, K., Almario, J. A., Brant, A., Borges, M. W., Siddiqui, A., Datta, L. W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15137 · Cited by 11
Self-citationColombo, F., Pintarelli, G., Galvan, A., Noci, S., Corli, O., Skorpen, F., Klepstad, P., Kaasa, S., Pigni, A., Brunelli, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57358-y · Cited by 11
Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
Donahue, T. R., & Dawson, D. W. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.009 · Cited by 11
Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Martelli, A. M., Cocco, L., Ratti, S., Follo, M. Y., Murata, R. M., Rosalen, P. L., et al. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.03.002 · Cited by 11
Screening for Pancreatic Cancer Gets a D, but the Student Is Improving
Hruban, R. H., & Lillemoe, K. D. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.2832 · Cited by 11
Self-citationLlach, J., Moreno, L., Sánchez, A., Herrera‐Pariente, C., Ocaña, T., Cuatrecasas, M., Rivero, L., Moreira, R., Díaz, M., Jung, G., et al. (2020) · Cancers · doi:10.3390/cancers12092386 · Cited by 11
Klein, A. P. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch124 · Cited by 11
Self-citationMaurer, E., Lehman, B., Matthäi, E., Denzer, U. W., Figiel, J. H., Jesinghaus, M., Slater, E. P., Stefenelli, U., Gress, T. M., & Bartsch, D. K. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12631 · Cited by 9
Hruban, R. H., Klimstra, D. S., Zamboni, G., & Klöppel, G. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.08.024 · Cited by 10
Self-citationNeoantigens and their clinical applications in human gastrointestinal cancers
Eshkiki, Z. S., Agah, S., Tabaeian, S. P., Sedaghat, M., Dana, F., Talebi, A., & Akbari, A. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02776-y · Cited by 10
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases
Mastracci, T. L., Apte, M. V., Amundadottir, L. T., Alvarsson, A., Artandi, S. E., Bellin, M. D., Bernal‐Mizrachi, E., Caicedo, A., Campbell‐Thompson, M., Cruz‐Monserrate, Z., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002170 · Cited by 10
Self-citationThe role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals
Overbeek, K. A., Cahen, D. L., & Bruno, M. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00380-5 · Cited by 11
DNA damage response and repair in pancreatic cancer development and therapy
Farnood, P. R., Pazhooh, R. D., Asemi, Z., & Yousefi, B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103116 · Cited by 11
Tan, M., Brusgaard, K., Gerdes, A., Mortensen, M. B., Detlefsen, S., de Muckadell, O. B. S., & Jøergensen, M. T. (2021) · Clinical Genetics · doi:10.1111/cge.14038 · Cited by 10
Vasen, H. F. A. (2017) · Familial Cancer · doi:10.1007/s10689-017-0066-y · Cited by 10
Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis
Lin, J., Boulling, A., Masson, E., Cooper, D. N., Li, Z., Férec, C., Liao, Z., & Chen, J. (2019) · Gut · doi:10.1136/gutjnl-2019-318564 · Cited by 10
Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma
Blair, A. B., Radomski, S. N., Chou, J. F., Liu, M., Howell, T. C., Park, W., O'Reilly, E. M., Zheng, L., Balachandran, V. P., Wei, A. C.-C., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16331-4 · Cited by 9
Metadata
- Authors
- Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., Stoffel, E., Syngal, S., Zogopoulos, G., Ali, S. Z., Axilbund, J., Chaffee, K. G., Chen, Y.-C., Cote, M. L., Childs, E. J., Douville, C., Goes, F. S., Herman, J. M., Iacobuzio-Donahue, C., Kramer, M., Makohon-Moore, A., McCombie, R. W., McMahon, K. W., Niknafs, N., Parla, J., Pirooznia, M., Potash, J. B., Rhim, A. D., Smith, A. L., Wang, Y., Wolfgang, C. L., Wood, L. D., Zandi, P. P., Goggins, M., Karchin, R., Eshleman, J. R., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Hruban, R. H., & Klein, A. P.
- Affiliations
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- 6Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Memorial Sloan Kettering Cancer Center (US)
- Abramson Cancer Center (US)
- Wayne State University (US)
- University of Michigan (US)
- Brigham and Women's Hospital (US)
- Research Institute of the McGill University Health Centre (CA)
- 3Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
- 15Department of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland.
- 10Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
- 19Memorial Sloan Kettering Cancer Center, New York, New York.
- Cold Spring Harbor Laboratory (US)
- 20Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
- University of Iowa (US)
- Corresponding author
- Roberts, Nicholas J.
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- ORCID
- Roberts, Nicholas J.
- Norris, Alexis L.
- Petersen, Gloria M.
- Bondy, Melissa L.
- Brand, Randall
- Kurtz, Robert C.
- Olson, Sara H.
- Rustgi, Anil K.
- Schwartz, Ann G.
- Stoffel, Elena
- Syngal, Sapna
- Zogopoulos, George
- Ali, Syed Z.
- Douville, Christopher
- Goes, Fernando S.
- Herman, Joseph M.
- Kramer, Melissa
- Makohon-Moore, Alvin
- Niknafs, Noushin
- Pirooznia, Mehdi
- Potash, James B.
- Rhim, Andrew D.
- Smith, Alyssa L.
- Wang, Yuxuan
- Wolfgang, Christopher L.
- Wood, Laura D.
- Zandi, Peter P.
- Goggins, Michael
- Karchin, Rachel
- Eshleman, James R.
- Papadopoulos, Nickolas
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- Venue
- Cancer Discovery
- Published
- 2016-02-01
- Volume
- 6
- Issue
- 2
- Pages
- 166-175
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4744563
- OpenAlex
- W2232697670
- Cited by
- 361
- References
- 49
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 42 · 2023: 33 · 2022: 30 · 2021: 58 · 2020: 41 · 2019: 43 · 2018: 35 · 2017: 32 · 2016: 18
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000371, 5p30ca045508-35)
- National Institute of Mental Health (R01MH087979, K01MH093809)
- National Cancer Institute (K99CA190889, R01CA-97075, R01-CA57345, R01CA154823, R00CA190889, R37CA043460, P50CA102701, R01CA057345, P30-CA045508, R01CA097075, R01CA177857, P50CA062924, R37CA057345, P30CA008748, P30CA015083, P30CA006973)
- National Institute of General Medical Sciences (T32GM007309, T32GM007057, T32GM008752)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060694)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- familial pancreatic cancer, pancreatic ductal adenocarcinoma, germline mutations, cancer susceptibility genes, BRCA2, CDKN2A, ATM, somatic mutations, hematopoietic cells, genetic heterogeneity, hereditary cancer predisposition, rare deleterious variants
- MeSH terms
- Carcinoma, Humans, Pancreatic Neoplasms, Point Mutation, Sequence Analysis, DNA, Germ-Line Mutation, Cyclin-Dependent Kinase Inhibitor p16, Genetic Predisposition to Disease, BRCA2 Protein, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
